OBJECTIVES: To date, separate condition-specific instruments have been used to assess severity of symptoms, in men and women with urological pain conditions. We developed a single instrument that can be used to assess treatment response in clinical trials and cohort studies that involve both genders. METHODS: We developed the Genitourinary Pain Index (GUPI) by modifying and adding questions to the National Institutes of Health-Chronic Prostatitis Symptom Index. To assess discriminant validity, concurrent validity, and reliability, we administered the GUPI to 1653 men and 1403 women in a large managed care population. To assess responsiveness, we administered the GUPI to 47 men and women who completed a National Institutes of Health-sponsored trial of pelvic floor physical therapy. RESULTS: The GUPI discriminated between men with chronic prostatitis or interstitial cystitis, those with other symptomatic conditions (dysuria, frequency, chronic cystitis), and those with none of these diagnoses (P <.05). It also discriminated between women with interstitial cystitis, those with incontinence, and those with none of these diagnoses (P <.05). The GUPI demonstrated good internal consistency within subscale domains, and GUPI scores correlated highly with scores on the Interstitial Cystitis Symptom Index and Problem Index. The GUPI was highly responsive to change, and the change in score was similar in both male and female responders. A reduction of 7 points robustly predicted being a treatment responder (sensitivity 100%, specificity 76%). CONCLUSIONS: The GUPI is a valid, reliable, and responsive instrument that can be used to assess the degree of symptoms in both men and women with genitourinary pain complaints.
OBJECTIVES: To date, separate condition-specific instruments have been used to assess severity of symptoms, in men and women with urological pain conditions. We developed a single instrument that can be used to assess treatment response in clinical trials and cohort studies that involve both genders. METHODS: We developed the Genitourinary Pain Index (GUPI) by modifying and adding questions to the National Institutes of Health-Chronic Prostatitis Symptom Index. To assess discriminant validity, concurrent validity, and reliability, we administered the GUPI to 1653 men and 1403 women in a large managed care population. To assess responsiveness, we administered the GUPI to 47 men and women who completed a National Institutes of Health-sponsored trial of pelvic floor physical therapy. RESULTS: The GUPI discriminated between men with chronic prostatitis or interstitial cystitis, those with other symptomatic conditions (dysuria, frequency, chronic cystitis), and those with none of these diagnoses (P <.05). It also discriminated between women with interstitial cystitis, those with incontinence, and those with none of these diagnoses (P <.05). The GUPI demonstrated good internal consistency within subscale domains, and GUPI scores correlated highly with scores on the Interstitial Cystitis Symptom Index and Problem Index. The GUPI was highly responsive to change, and the change in score was similar in both male and female responders. A reduction of 7 points robustly predicted being a treatment responder (sensitivity 100%, specificity 76%). CONCLUSIONS: The GUPI is a valid, reliable, and responsive instrument that can be used to assess the degree of symptoms in both men and women with genitourinary pain complaints.
Authors: J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe-Rosetti; Sara Y Gao; Sheila O Brown; Elizabeth A Calhoun Journal: J Urol Date: 2006-08 Impact factor: 7.450
Authors: J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe Rosetti; Sheila O Brown; Sara Y Gao; Elizabeth A Calhoun Journal: J Urol Date: 2005-08 Impact factor: 7.450
Authors: J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe Rosetti; Sara Y Gao; Elizabeth A Calhoun Journal: J Urol Date: 2005-12 Impact factor: 7.450
Authors: M S Litwin; M McNaughton-Collins; F J Fowler; J C Nickel; E A Calhoun; M A Pontari; R B Alexander; J T Farrar; M P O'Leary Journal: J Urol Date: 1999-08 Impact factor: 7.450
Authors: Robert Mayer; Kathleen Joy Propert; Kenneth M Peters; Christopher K Payne; Yawei Zhang; David Burks; Daniel J Culkin; Ananias Diokno; Philip Hanno; J Richard Landis; Rosemary Madigan; Edward M Messing; J Curtis Nickel; Grannum R Sant; John Warren; Alan J Wein; John W Kusek; Leroy M Nyberg; Harris E Foster Journal: J Urol Date: 2005-04 Impact factor: 7.450
Authors: G R Sant; K J Propert; P M Hanno; D Burks; D Culkin; A C Diokno; C Hardy; J R Landis; R Mayer; R Madigan; E M Messing; K Peters; T C Theoharides; J Warren; A J Wein; W Steers; J W Kusek; L M Nyberg Journal: J Urol Date: 2003-09 Impact factor: 7.450
Authors: Mary P FitzGerald; Rodney U Anderson; Jeannette Potts; Christopher K Payne; Kenneth M Peters; J Quentin Clemens; Rhonda Kotarinos; Laura Fraser; Annemarie Cosby; Carole Fortman; Cynthia Neville; Suzanne Badillo; Lisa Odabachian; Andrea Sanfield; Betsy O'Dougherty; Rick Halle-Podell; Liyi Cen; Shannon Chuai; J Richard Landis; Keith Mickelberg; Ted Barrell; John W Kusek; Leroy M Nyberg Journal: J Urol Date: 2009-06-17 Impact factor: 7.450
Authors: Lisa A Kilpatrick; Jason J Kutch; Kirsten Tillisch; Bruce D Naliboff; Jennifer S Labus; Zhiguo Jiang; Melissa A Farmer; A Vania Apkarian; Sean Mackey; Katherine T Martucci; Daniel J Clauw; Richard E Harris; Georg Deutsch; Timothy J Ness; Claire C Yang; Kenneth Maravilla; Chris Mullins; Emeran A Mayer Journal: J Urol Date: 2014-03-26 Impact factor: 7.450
Authors: Cindy L Amundsen; Margaret E Helmuth; Abigail R Smith; John O L DeLancey; Catherine S Bradley; Kathryn E Flynn; Kimberly S Kenton; H Henry Lai; David Cella; James W Griffith; Victor P Andreev; J Eric Jelovsek; Alice B Liu; Ziya Kirkali; Claire C Yang Journal: Neurourol Urodyn Date: 2019-11-25 Impact factor: 2.696
Authors: David Cella; Abigail R Smith; James W Griffith; Kathryn E Flynn; Catherine S Bradley; Brenda W Gillespie; Ziya Kirkali; Pooja Talaty; J Eric Jelovsek; Brian T Helfand; Kevin P Weinfurt Journal: Neurourol Urodyn Date: 2019-06-21 Impact factor: 2.696
Authors: Adelle Dagher; Adam Curatolo; Monisha Sachdev; Alisa J Stephens; Chris Mullins; J Richard Landis; Adrie van Bokhoven; Andrew El-Hayek; John W Froehlich; Andrew C Briscoe; Roopali Roy; Jiang Yang; Michel A Pontari; David Zurakowski; Richard S Lee; Marsha A Moses Journal: BJU Int Date: 2017-04-11 Impact factor: 5.588
Authors: Andrew Schrepf; Bruce Naliboff; David A Williams; Alisa J Stephens-Shields; J Richard Landis; Arpana Gupta; Emeran Mayer; Larissa V Rodriguez; Henry Lai; Yi Luo; Catherine Bradley; Karl Kreder; Susan K Lutgendorf Journal: Ann Behav Med Date: 2018-09-13
Authors: J Quentin Clemens; Alisa Stephens-Shields; Bruce D Naliboff; H Henry Lai; Larissa Rodriguez; John N Krieger; David A Williams; John W Kusek; J Richard Landis Journal: J Urol Date: 2018-01-04 Impact factor: 7.450
Authors: Gang Liu; Victor P Andreev; Margaret E Helmuth; Claire C Yang; H Henry Lai; Abigail R Smith; Jonathan B Wiseman; Robert M Merion; Bradley A Erickson; David Cella; James W Griffith; John L Gore; John O L DeLancey; Ziya Kirkali Journal: J Urol Date: 2019-05-23 Impact factor: 7.450
Authors: J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis Journal: Nat Rev Urol Date: 2019-03 Impact factor: 14.432
Authors: Larissa V Rodríguez; Alisa J Stephens; J Quentin Clemens; Dedra Buchwald; Claire Yang; Henry H Lai; John N Krieger; Craig Newcomb; Cate S Bradley; Bruce Naliboff Journal: Urology Date: 2018-11-16 Impact factor: 2.649